Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trialDeepak Cyril D’Souza, Patrick D. Skosnik, Halle Thurnauer et al.|The Lancet Psychiatry|2018Cited by 194
168. The Effect of Fatty Acid Amide Hydrolase Inhibition on Sleep Architecture in Cannabis WithdrawalPatrick D. Skosnik, Deepak Cyril D’Souza, Jose Cortes-Briones et al.|Biological Psychiatry|2018Cited by 1